Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management firm, again showing support for the biopharma sector (See recent buy of Cybin (NYSE: CYBN) shares.)
The Australia-based company currently trades on the Nasdaq and in the Frankfurt Stock Exchange (Fra) by means of American Depositary Shares (ADS) and recently announced its delisting intentions from the Australian Securities Exchange (ASX) following a U.S.-focused transformation plan. Read more HERE.
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
Governor Gavin Newsom (D) signed two of several psychedelics and marijuana proposals.
AB1021 enables “a physician, pharmacist, or other authorized healing arts licensee acting within their scope of practice” to prescribe and dispense current Schedule I drugs -including the designated “breakthrough therapies” concerning psilocybin and MDMA- once their federal status changes. Read more HERE.
Maine's Portland Leads Drug Policy Reform Decriminalizing Psychedelic Plants And Fungi + Weekly States Update
The City Council in Portland, Maine voted 6-3 in favor of a resolution deprioritizing local law enforcement for possession, use, cultivation for personal use, or sharing psychedelic plants and fungi, placing controlled substances consumption as a public health matter. Read more HERE.
Check out this ...